Company:Avalere Health
Avalere, a part of Avalere Health, is a health care business consulting firm headquartered in Washington, D.C., specializing in strategy, policy, and data analysis for life sciences, health plans, providers, government agencies, and industry associations. The company also publishes research studies on health care issues and the health care reform debate in the United States.
History
Avalere was founded as The Health Strategies Consultancy LLC in 2000 by Dan Mendelson. In 2008, Mendelson sold a minority interest of the company to ABS Capital Partners, a Baltimore, Maryland–based private equity firm.[1] On September 1, 2015, Inovalon (Nasdaq: INOV), a leading technology company headquartered in Bowie, Maryland, providing an integrated cloud-based platform that enables healthcare organizations to implement large-scale highly sophisticated data-driven initiatives, acquired Avalere.[2][3] Avalere operated as a subsidiary with a focus on providing advisory services on market consolidation, cost management, quality improvement, and managed care as well as business intelligence and corporate communication strategies. The firm has also published studies on drug plan coverage and managed care plans in the US.[4][5][6][7] Avalere was acquired by Avalere Health (previously known as Fishawack Health) in June 2022.[8]
References
- ↑ "Maryland's ABS Capital Partners Buys Minority Stake in D.C.'s Avalere". TechJournal. April 29, 2008. Archived from the original on 2015-05-30. https://web.archive.org/web/20150530001731/http://www.techjournal.org/2008/04/marylands-abs-capital-partners-buys-minority-stake-in-dcs-avalere/.
- ↑ "Inovalon Completes Previously Announced Acquisition of Avalere". Inovalon. September 1, 2015. http://www.inovalon.com/press-releases/2015/inovalon-completes-previously-announced-acquisition-avalere.
- ↑ "Avalere Joins Inovalon". Avalere (Press release). September 1, 2015.
- ↑ "How expensive medications are increasingly out of reach". The Washington Post. March 31, 2013. https://www.washingtonpost.com/blogs/wonkblog/wp/2015/03/13/how-expensive-medications-are-increasingly-out-of-reach/.
- ↑ "Concern Over Drug Costs". The New York Times. September 17, 2013. https://www.nytimes.com/2013/09/18/business/concern-grows-over-cost-of-drugs-under-new-health-care-law.html.
- ↑ Andrews, Michelle (October 3, 2014). "What You Need to Know for Medicare Open Enrollment". NPR. https://www.npr.org/sections/health-shots/2014/10/03/353256972/what-you-need-to-know-for-medicare-open-enrollment.
- ↑ "Private Insurers Net 9.3 Million from ACA's Medicaid Expansion". Forbes. December 17, 2014. https://www.forbes.com/sites/brucejapsen/2014/12/17/private-insurers-net-9-3-million-from-acas-medicaid-expansion/.
- ↑ "Fishawack buys DC policy and market access shop Avalere". Medical Marketing and Media. June 7, 2022. https://www.mmm-online.com/home/channel/the-wire/fishawack-buys-dc-policy-and-market-access-shop-avalere/.
Further reading
- Avalere Health (June 6, 2014). "Estimated Impact on the Federal Deficit and Insurance Premiums from Creating a New Health Plan Tier with an Actuarial Value Level of 50 Percent". Archived from the original on 2014-09-08. https://web.archive.org/web/20140908071040/http://cahc.net/wp-content/uploads/2014/08/20140605-CAHC-New-50-AV-Tier-Score.pdf. (Report to the Council for Affordable Health Coverage)
- Mendelson, Dan (June 27, 2011). Establishing Sensible Cost Sharing for Medicare Cancer Patients. Health Affairs Blog. doi:10.1377/forefront.20110624.012009. https://www.healthaffairs.org/do/10.1377/forefront.20110624.012009.
External links
 |  |
